Dr. Krishna Reddy Taduri highlights the rising prevalence of diabetes, particularly among younger populations, and stresses the importance of early detection and lifestyle changes…
This article discusses the potential risks associated with discontinuing GLP-1 medications like Ozempic and Zepbound, as outlined by Dr. Frank Dumont. Patients may experience rene…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
More matching stories may be available further back in the archive.